Latest filing published 01 Dec 2022 for Boule Diagnostics AB Teckningsoptionsprogram serie 2014:1, €601k.
Insider track record
No signal scores available.
Thomas Eklund: trading record in brief
Thomas Eklund discloses dealings in 2 companies, chiefly Boul BTA and Boule Diagnostics AB Teckningsoptionsprogram serie 2014:1. In total, 4 filings cover trades dated from 29 November 2022 to 30 November 2022.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Most recently, on 1 December 2022, the filings show a transaction worth €601k in Boule Diagnostics AB Teckningsoptionsprogram serie 2014:1. The median gap between a trade and its publication by Finansinspektionen is 2 days. For comparison, MAR article 19 gives managers three business days to notify a trade. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Companies and markets linked to Thomas Eklund
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 851,916 shares@ SEK 7.7093.6% of flowBTA (betald tecknad aktie)ISIN SE0018768186FI:csv-b4f0a21f520665387812
- 57,969 shares@ SEK 7.706.4% of flowBTA (betald tecknad aktie)ISIN SE0018768186FI:csv-e5ea935cabc104fa42bd
- 1,104,139 shares@ SEK 7.7093.7% of flowBTA (betald tecknad aktie)ISIN SE0018768186FI:csv-ecaf49dd23073189a621
- 74,621 shares@ SEK 7.706.3% of flowBTA (betald tecknad aktie)ISIN SE0018768186FI:csv-2bb01e65ad3ea0880079
4 of 4 declarations